Has Connie Dunn received payments from drug or device companies?

Yes. Drug and device makers reported $2,375 in general payments to Connie Dunn across 147 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Connie Dunn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Connie Dunn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Connie Dunn

Gerontology · Mexico, MONPI 1801899661

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Dexcom, Inc. at 32.8% of the total. Reporting peaked in 2022 at $1,404 and has fallen 61.0% since, to $547 in 2023.

$2,375in general payments, 2019–2025

Across 147 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dexcom, Inc.$778
Sanofi-aventis U.S. LLC$252
Novo Nordisk$245
AbbVie$193
Abbott$166
Amgen$91
plus $649 from 15 others

What the payments were for

Food & beverage$2,363100%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dexcom, Inc.	58	$778
Sanofi-aventis U.S. LLC	9	$252
Novo Nordisk	25	$245
AbbVie	10	$193
Abbott	4	$166
Amgen	5	$91
Boehringer Ingelheim	5	$86
Lilly USA, LLC	4	$86
Nevro Corp.	4	$75
AstraZeneca	4	$70
Bayer	4	$67
Ascensia Diabetes Care US Inc.	2	$45
Medtronic	2	$40
Merck	2	$34
Melinta Therapeutics, LLC	2	$32
Organogenesis Inc.	2	$27
Shionogi Inc	1	$22
Averitas Pharma Inc.	1	$20
Kyowa Kirin, Inc.	1	$17
Insulet Corporation	1	$14
Tandem Diabetes Care, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FreeStyle Libre$122
SOLIQUA 100/33$103

How this compares

$2,375 in reported general payments places this provider in the 85th percentile of 175 gerontology providers in Missouri.

See all gerontology providers in Missouri →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	13	$2,020
Glimepiride	18	$83

Paid to pharmacies, not to this prescriber.

Other gerontology in Mexico

Tonia NeriniBevier$29K
Melissa DusenberryKansas City$8K
Kelly DaltonSpringfield$8K
Laura TullisKansas City$7K
Marissa SaengsamranSaint Louis$6K
Matthew RobertsBridgeton$6K
Amy GuanSaint Louis$5K
Kayla WeissSaint Louis$5K
Robin BobinmyerHumansville$5K
Rutendo KamudzanduIndependence$5K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →